233 related articles for article (PubMed ID: 22434651)
1. Heparin-modified small-diameter nanofibrous vascular grafts.
Janairo RR; Henry JJ; Lee BL; Hashi CK; Derugin N; Lee R; Li S
IEEE Trans Nanobioscience; 2012 Mar; 11(1):22-7. PubMed ID: 22434651
[TBL] [Abstract][Full Text] [Related]
2. End-point immobilization of heparin on plasma-treated surface of electrospun polycarbonate-urethane vascular graft.
Qiu X; Lee BL; Ning X; Murthy N; Dong N; Li S
Acta Biomater; 2017 Mar; 51():138-147. PubMed ID: 28069505
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of small-diameter vascular scaffolds by heparin-bonded P(LLA-CL) composite nanofibers to improve graft patency.
Wang S; Mo XM; Jiang BJ; Gao CJ; Wang HS; Zhuang YG; Qiu LJ
Int J Nanomedicine; 2013; 8():2131-9. PubMed ID: 23776333
[TBL] [Abstract][Full Text] [Related]
4. Mucin covalently bonded to microfibers improves the patency of vascular grafts.
Janairo RR; Zhu Y; Chen T; Li S
Tissue Eng Part A; 2014 Jan; 20(1-2):285-93. PubMed ID: 23962121
[TBL] [Abstract][Full Text] [Related]
5. Engineering the mechanical and biological properties of nanofibrous vascular grafts for in situ vascular tissue engineering.
Henry JJD; Yu J; Wang A; Lee R; Fang J; Li S
Biofabrication; 2017 Aug; 9(3):035007. PubMed ID: 28817384
[TBL] [Abstract][Full Text] [Related]
6. Nanofibrous vascular scaffold prepared from miscible polymer blend with heparin/stromal cell-derived factor-1 alpha for enhancing anticoagulation and endothelialization.
Wang W; Liu D; Li D; Du H; Zhang J; You Z; Li M; He C
Colloids Surf B Biointerfaces; 2019 Sep; 181():963-972. PubMed ID: 31382347
[TBL] [Abstract][Full Text] [Related]
7. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
[TBL] [Abstract][Full Text] [Related]
8. Vascular Remodeling Process of Heparin-Conjugated Poly(ε-Caprolactone) Scaffold in a Rat Abdominal Aorta Replacement Model.
Xu Z; Gu Y; Li J; Feng Z; Guo L; Tong Z; Ye L; Wang C; Wang R; Geng X; Wang C; Zhang J
J Vasc Res; 2018; 55(6):338-349. PubMed ID: 30485863
[TBL] [Abstract][Full Text] [Related]
9. Preparation of Small-Diameter Tissue-Engineered Vascular Grafts Electrospun from Heparin End-Capped PCL and Evaluation in a Rabbit Carotid Artery Replacement Model.
Jin X; Geng X; Jia L; Xu Z; Ye L; Gu Y; Zhang AY; Feng ZG
Macromol Biosci; 2019 Aug; 19(8):e1900114. PubMed ID: 31222914
[TBL] [Abstract][Full Text] [Related]
10. Appropriate density of PCL nano-fiber sheath promoted muscular remodeling of PGS/PCL grafts in arterial circulation.
Yang X; Wei J; Lei D; Liu Y; Wu W
Biomaterials; 2016 May; 88():34-47. PubMed ID: 26943048
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Patency and Endothelialization of Small-Caliber Vascular Grafts Fabricated by Coimmobilization of Heparin and Cell-Adhesive Peptides.
Choi WS; Joung YK; Lee Y; Bae JW; Park HK; Park YH; Park JC; Park KD
ACS Appl Mater Interfaces; 2016 Feb; 8(7):4336-46. PubMed ID: 26824876
[TBL] [Abstract][Full Text] [Related]
12. Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts.
Hashi CK; Zhu Y; Yang GY; Young WL; Hsiao BS; Wang K; Chu B; Li S
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):11915-20. PubMed ID: 17615237
[TBL] [Abstract][Full Text] [Related]
13. Novel bioengineered small caliber vascular graft with excellent one-month patency.
Ishii Y; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Schuessler RB; Damiano RJ
Ann Thorac Surg; 2007 Feb; 83(2):517-25. PubMed ID: 17257981
[TBL] [Abstract][Full Text] [Related]
14. Antithrombogenic modification of small-diameter microfibrous vascular grafts.
Hashi CK; Derugin N; Janairo RR; Lee R; Schultz D; Lotz J; Li S
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1621-7. PubMed ID: 20466974
[TBL] [Abstract][Full Text] [Related]
15. Comparison of plasma and chemical modifications of poly-L-lactide-co-caprolactone scaffolds for heparin conjugation.
Hsieh YF; Sahagian K; Huang F; Xu K; Patel S; Li S
Biomed Mater; 2017 Oct; 12(6):065004. PubMed ID: 28980527
[TBL] [Abstract][Full Text] [Related]
16. Hybrid small-diameter vascular grafts: Anti-expansion effect of electrospun poly ε-caprolactone on heparin-coated decellularized matrices.
Gong W; Lei D; Li S; Huang P; Qi Q; Sun Y; Zhang Y; Wang Z; You Z; Ye X; Zhao Q
Biomaterials; 2016 Jan; 76():359-70. PubMed ID: 26561933
[TBL] [Abstract][Full Text] [Related]
17. Porcine carotid artery replacement with biodegradable electrospun poly-e-caprolactone vascular prosthesis.
Mrówczyński W; Mugnai D; de Valence S; Tille JC; Khabiri E; Cikirikcioglu M; Möller M; Walpoth BH
J Vasc Surg; 2014 Jan; 59(1):210-9. PubMed ID: 23707057
[TBL] [Abstract][Full Text] [Related]
18. Elasticity assessment of electrospun nanofibrous vascular grafts: a comparison with femoral ovine arteries.
Bagnasco DS; Ballarin FM; Cymberknop LJ; Balay G; Negreira C; Abraham GA; Armentano RL
Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():446-54. PubMed ID: 25491850
[TBL] [Abstract][Full Text] [Related]
19. The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration.
Yu J; Wang A; Tang Z; Henry J; Li-Ping Lee B; Zhu Y; Yuan F; Huang F; Li S
Biomaterials; 2012 Nov; 33(32):8062-74. PubMed ID: 22884813
[TBL] [Abstract][Full Text] [Related]
20. Development of small diameter nanofiber tissue engineered arterial grafts.
Kurobe H; Maxfield MW; Tara S; Rocco KA; Bagi PS; Yi T; Udelsman B; Zhuang ZW; Cleary M; Iwakiri Y; Breuer CK; Shinoka T
PLoS One; 2015; 10(4):e0120328. PubMed ID: 25830942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
